113 related articles for article (PubMed ID: 21129817)
21. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
[TBL] [Abstract][Full Text] [Related]
22. Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents.
Mendes RE; Rhomberg PR; Bell JM; Turnidge JD; Sader HS
Diagn Microbiol Infect Dis; 2009 Apr; 63(4):415-25. PubMed ID: 19249175
[TBL] [Abstract][Full Text] [Related]
23. Risk factors and clinical features of infections caused by plasmid-mediated AmpC beta-lactamase-producing Enterobacteriaceae.
Park YS; Yoo S; Seo MR; Kim JY; Cho YK; Pai H
Int J Antimicrob Agents; 2009 Jul; 34(1):38-43. PubMed ID: 19297134
[TBL] [Abstract][Full Text] [Related]
24. Late-onset ventilator-associated pneumonia in nontrauma intensive care unit patients.
Gacouin A; Barbarot N; Camus C; Salomon S; Isslame S; Marque S; Lavoué S; Donnio PY; Thomas R; Le Tulzo Y
Anesth Analg; 2009 Nov; 109(5):1584-90. PubMed ID: 19713267
[TBL] [Abstract][Full Text] [Related]
25. How Should We Treat Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae?
Timsit JF; Pilmis B; Zahar JR
Semin Respir Crit Care Med; 2017 Jun; 38(3):287-300. PubMed ID: 28578553
[TBL] [Abstract][Full Text] [Related]
26. Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia.
Nicasio AM; Eagye KJ; Kuti EL; Nicolau DP; Kuti JL
Pharmacotherapy; 2010 May; 30(5):453-62. PubMed ID: 20411997
[TBL] [Abstract][Full Text] [Related]
27. Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.
Czosnowski QA; Wood GC; Magnotti LJ; Croce MA; Swanson JM; Boucher BA; Fabian TC
Pharmacotherapy; 2009 Sep; 29(9):1054-60. PubMed ID: 19698010
[TBL] [Abstract][Full Text] [Related]
28. Ceftaroline fosamil for the treatment of hospital-acquired pneumonia and ventilator-associated pneumonia.
Kaye KS; Udeani G; Cole P; Friedland HD
Hosp Pract (1995); 2015; 43(3):144-9. PubMed ID: 25956849
[TBL] [Abstract][Full Text] [Related]
29. Susceptibility to penicillin derivatives among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
Mischnik A; Baumert P; Hamprecht A; Rohde A; Peter S; Feihl S; Knobloch J; Gölz H; Kola A; Obermann B; Querbach C; Willmann M; Gebhardt F; Tacconelli E; Gastmeier P; Seifert H; Kern WV;
Diagn Microbiol Infect Dis; 2017 Jan; 87(1):71-73. PubMed ID: 27769572
[TBL] [Abstract][Full Text] [Related]
30. Comparative in vitro activity of cefditoren and other antimicrobials against Enterobacteriaceae causing community-acquired uncomplicated urinary tract infections in women: a Spanish nationwide multicenter study.
Cuevas O; Cercenado E; Gimeno M; Marín M; Coronel P; Bouza E;
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):251-60. PubMed ID: 20542206
[TBL] [Abstract][Full Text] [Related]
31. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia.
Combes A; Luyt CE; Fagon JY; Wolff M; Trouillet JL; Chastre J
Crit Care Med; 2007 Jan; 35(1):146-54. PubMed ID: 17080004
[TBL] [Abstract][Full Text] [Related]
32. Utility of ampicillin-sulbactam for empiric treatment of ventilator-associated pneumonia in a trauma population.
McMillian WD; Bednarik JL; Aloi JJ; Ahern JW; Crookes BA
J Trauma; 2010 Oct; 69(4):861-5. PubMed ID: 20938272
[TBL] [Abstract][Full Text] [Related]
33. beta-Lactams without a suicide inhibitor.
Giamarellou H
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():194-7. PubMed ID: 18154547
[TBL] [Abstract][Full Text] [Related]
34. Infection-related ventilator-associated complications in ICU patients colonised with extended-spectrum β-lactamase-producing Enterobacteriaceae.
Barbier F; Bailly S; Schwebel C; Papazian L; Azoulay É; Kallel H; Siami S; Argaud L; Marcotte G; Misset B; Reignier J; Darmon M; Zahar JR; Goldgran-Toledano D; de Montmollin É; Souweine B; Mourvillier B; Timsit JF;
Intensive Care Med; 2018 May; 44(5):616-626. PubMed ID: 29663045
[TBL] [Abstract][Full Text] [Related]
35. [The changing patterns and the associated factors of microbial pathogens in ventilator-associated pneumonia in a respiratory intensive care unit from 1995 to 2004].
Yang W; He B; Zhao MW
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Aug; 31(8):598-602. PubMed ID: 19080406
[TBL] [Abstract][Full Text] [Related]
36. Bacteriological profile of ventilator-associated pneumonia in a tertiary care hospital.
Patro S; Sarangi G; Das P; Mahapatra A; Mohapatra D; Paty BP; Chayani N
Indian J Pathol Microbiol; 2018; 61(3):375-379. PubMed ID: 30004058
[TBL] [Abstract][Full Text] [Related]
37. Value of APACHE II, SOFA and CPIS scores in predicting prognosis in patients with ventilator-associated pneumonia.
Gursel G; Demirtas S
Respiration; 2006; 73(4):503-8. PubMed ID: 16205047
[TBL] [Abstract][Full Text] [Related]
38. Incidence and risk factors for the development of acute renal failure in patients with ventilator-associated pneumonia.
Gursel G; Demir N
Nephrology (Carlton); 2006 Jun; 11(3):159-64. PubMed ID: 16756626
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004).
Goossens H; Grabein B
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):257-64. PubMed ID: 16360549
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for relapse of ventilator-associated pneumonia related to nonfermenting Gram negative bacilli: a case-control study.
Nseir S; Deplanque X; Di Pompeo C; Diarra M; Roussel-Delvallez M; Durocher A
J Infect; 2008 May; 56(5):319-25. PubMed ID: 18405975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
